Investor Atlas

2080 Ventures · Investor research

75 Series D investors targeting France

Compare 75 Series D investors targeting France. Review the selection, investor types and reported focus with 2080 Ventures.

75matching investors
0individual investors
75organizations

What this selection covers

This guide contains 75 distinct directory identities matching target markets: France; funding stages & types: Series D. Counts describe Investor Atlas coverage, not the size of the market or currently available capital.

“Targeting France” means the source explicitly lists this investment market. These investors may be headquartered elsewhere. Worldwide or regional labels are not expanded into individual countries.

Series D is a reported funding-stage or financing-type tag. Business milestones such as prototype or early revenue are kept separate.

Investor types represented: Venture Capital (68), Family Office (5), Corporate Venture Capital (4), Private Equity (4).

Common reported sector tags: SaaS (55), Healthcare (54), Fintech (51), AI & ML (40). Investors can have multiple tags.

Prepare a focused approach

Start with the sector and business model you operate in, then narrow by funding round, target market and investor type.

Before pitching for France, confirm incorporation requirements, team location and whether the mandate supports market entry or only established local operations.

For Series D, show the evidence already achieved, the next milestone and a budget connecting the raise to that milestone. Confirm expected round size and ownership.

  1. Check the current mandate and recent investments.
  2. Confirm check size, lead or follow preference, and company eligibility.
  3. Identify the relevant partner and published pitch route.
  4. Explain your customer evidence, raise and specific reason for approaching this investor.

Explore the 75 matching investors

Listed alphabetically, without ranking by performance or likelihood of investment. Full profiles, investment criteria and available contact details require sign-in.

InvestorInvestor typeResearch
83North
Venture CapitalView profile ↗
A Plus Finance
Investment OrganizationView profile ↗
Abingworth
Venture CapitalView profile ↗
Act Venture Capital
Venture CapitalView profile ↗
Advent Life Sciences
Venture CapitalView profile ↗
Alven
Venture CapitalView profile ↗
Amadeus Capital Partners
Venture CapitalView profile ↗
Andreessen Horowitz
Venture CapitalView profile ↗
Arts Alliance
Family Office, Venture CapitalView profile ↗
Atlantic Bridge
Venture CapitalView profile ↗
Atomico
Venture CapitalView profile ↗
Austin Ventures
Venture CapitalView profile ↗
Balderton Capital
Venture CapitalView profile ↗
Battery Ventures
Venture CapitalView profile ↗
Bessemer Venture Partners
Venture CapitalView profile ↗
Bosch Ventures
Venture Capital, Corporate Venture CapitalView profile ↗
Cathay Innovation
Venture CapitalView profile ↗
Cipio Partners
Venture CapitalView profile ↗
Commerce Ventures
Venture CapitalView profile ↗
Creandum
Venture CapitalView profile ↗
Dawn Capital
Venture CapitalView profile ↗
Demeter
Venture CapitalView profile ↗
DN Capital
Venture CapitalView profile ↗
Entrée Capital
Venture CapitalView profile ↗
EQT Ventures
Venture Capital, Family OfficeView profile ↗
Eurazeo
Private EquityView profile ↗
Evolution Equity Partners
Venture CapitalView profile ↗
Felix Capital
Venture CapitalView profile ↗
Fin Capital
Venture CapitalView profile ↗
Finch Capital
Venture CapitalView profile ↗
FMO
Investment OrganizationView profile ↗
Forbion Capital Partners
Venture CapitalView profile ↗
General Catalyst
Venture CapitalView profile ↗
Generation Investment Management
Investment OrganizationView profile ↗
Genoa Ventures
Venture CapitalView profile ↗
Gilde Healthcare
Venture CapitalView profile ↗
Gimv
Private EquityView profile ↗
Global Founders Capital
Venture Capital, Family OfficeView profile ↗
Goodwater Capital
Venture CapitalView profile ↗
GR Capital
Venture CapitalView profile ↗
Greenoaks
Venture CapitalView profile ↗
HealthCap
Venture CapitalView profile ↗
Highland Europe
Venture CapitalView profile ↗
IDInvest Partners
Private EquityView profile ↗
Index Ventures
Venture CapitalView profile ↗
InterWest Partners
Venture CapitalView profile ↗
Iris Capital
Venture CapitalView profile ↗
Keiretsu Forum
Venture Capital, Angel NetworkView profile ↗
Khosla Ventures
Venture CapitalView profile ↗
Mangrove Capital Partners
Venture CapitalView profile ↗
Medicxi
Venture CapitalView profile ↗
Morgenthaler Ventures
Venture CapitalView profile ↗
Next47
Venture Capital, Corporate Venture CapitalView profile ↗
Northzone
Venture CapitalView profile ↗
Novartis Venture Fund
Venture Capital, Corporate Venture CapitalView profile ↗
Novo Holdings
Venture Capital, Corporate Venture CapitalView profile ↗
Permira
Private EquityView profile ↗
Piton Capital
Venture CapitalView profile ↗
Prime Ventures
Venture CapitalView profile ↗
Project A Ventures
Venture CapitalView profile ↗
Quiet Capital
Venture CapitalView profile ↗
Raine Ventures
Venture Capital, Family OfficeView profile ↗
Ribbit Capital
Venture CapitalView profile ↗
Runa Capital
Venture CapitalView profile ↗
Scottish Equity Partners
Venture CapitalView profile ↗
Sequoia Capital
Venture CapitalView profile ↗
Serena
Venture CapitalView profile ↗
Seventure Partners
Venture CapitalView profile ↗
Sofinnova Partners
Venture CapitalView profile ↗
Summit Partners
Venture CapitalView profile ↗
Target Global
Venture CapitalView profile ↗
The Westly Group
Venture CapitalView profile ↗
Ventech
Venture CapitalView profile ↗
Wellington Partners
Venture CapitalView profile ↗
White Star Capital
Venture Capital, Family OfficeView profile ↗

How these guides are compiled. Source-reported criteria may change. A listing does not confirm current investment activity.